What is the diagnosis and treatment for Mobitz type I (Wenckebach) second-degree atrioventricular (AV) block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025 • View editorial policy

From the Guidelines

Mobitz Type I second-degree AV block is a cardiac conduction abnormality that rarely requires permanent pacing, but may be considered in highly symptomatic patients who don't respond to medication adjustments, as recommended by the 2019 ACC/AHA/HRS guideline 1.

Diagnosis and Treatment

Mobitz Type I second-degree AV block, also known as Wenckebach phenomenon, is characterized by progressive prolongation of the PR interval on ECG until a beat is completely blocked, followed by a reset of the cycle. This condition occurs due to gradual impairment of conduction through the AV node, typically resulting from increased vagal tone, medication effects, or ischemia.

Key Considerations

  • Most patients with Mobitz Type I are asymptomatic and require no specific treatment if they remain hemodynamically stable.
  • For symptomatic patients, atropine (0.5-1 mg IV) may be administered to increase heart rate temporarily, as suggested by the 1996 ACC/AHA guidelines 2.
  • If medications are causing the block, they should be discontinued or their dosages reduced, particularly beta-blockers, calcium channel blockers, or digoxin.
  • Underlying causes such as myocardial ischemia should be addressed.
  • Unlike Mobitz Type II, Mobitz Type I rarely progresses to complete heart block and generally has a benign prognosis.

Management and Monitoring

  • Patients should be monitored periodically with ECGs to ensure the condition doesn't worsen.
  • Permanent pacemaker implantation is rarely needed for Mobitz Type I, but may be considered in highly symptomatic patients who don't respond to medication adjustments, as stated in the 2019 ACC/AHA/HRS guideline 1.
  • The guideline recommends permanent pacing for patients with marked first-degree or second-degree Mobitz type I (Wenckebach) atrioventricular block with symptoms that are clearly attributable to the atrioventricular block, with a class IIa recommendation and level of evidence C-LD 1.

From the Research

Diagnosis of Mobitz Type I Second-Degree AV Block

  • The diagnosis of Mobitz Type I second-degree atrioventricular (AV) block is characterized by a visible, differing, and generally decremental AV conduction 3.
  • It is also known as Wenckebach second-degree AV block, which describes a lengthening PR interval consistent with second-degree AV block - Mobitz Type I 4.
  • The site of the block in Mobitz Type I is usually within the AV node 5.

Treatment of Mobitz Type I Second-Degree AV Block

  • The treatment of Mobitz Type I second-degree AV block depends on the underlying cause and the presence of symptoms.
  • In some cases, aminophylline may be effective in improving AV conduction in atropine-resistant late advanced AV block complicating acute inferior myocardial infarction, including Mobitz Type I AV block 6.
  • However, the use of aminophylline is not a standard treatment for Mobitz Type I second-degree AV block, and its effectiveness may vary depending on the individual case.
  • In general, pacing is not required for Mobitz Type I second-degree AV block unless it is associated with symptoms or other underlying conditions that require pacing 3.

Differential Diagnosis

  • Second-degree AV block must be distinguished from other causes of pauses, including nonconducted premature atrial contractions and atrial tachycardia with block 5.
  • Concealed (nonpropagated) His bundle or ventricular extrasystoles may mimic both type I and/or type II block (pseudo AV block) 3.
  • A pattern resembling a narrow QRS type II block in association with an obvious type I structure in the same recording effectively rules out type II block because the coexistence of both types of narrow QRS block is exceedingly rare 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.